LON:GNS Genus (GNS) Share Price, News & Analysis → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free GNS Stock Alerts GBX 1,850 -30.00 (-1.60%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range 1,842▼ 1,91250-Day Range 1,700▼ 1,89852-Week Range 1,478▼ 2,572Volume31,130 shsAverage Volume97,732 shsMarket Capitalization£1.22 billionP/E Ratio3,627.45Dividend Yield1.73%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades Get Genus alerts: Email Address Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… About Genus Stock (LON:GNS)Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.Read More GNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNS Stock News HeadlinesMay 7, 2024 | lse.co.ukLondon open: Stocks rally as investors mull retail sales, house pricesMay 3, 2024 | lse.co.ukLondon midday: Stocks extend gains as Anglo rallies; payrolls eyedApril 22, 2024 | finance.yahoo.comWith 83% institutional ownership, Genus plc (LON:GNS) is a favorite amongst the big gunsApril 2, 2024 | msn.comFact Check: Video Claimed Scuba Diver Swam With Dinosaur. Here's the TruthMarch 14, 2024 | msn.comShould I buy the current dogs of the FTSE 250?February 25, 2024 | finance.yahoo.comGenus plc (LON:GNS) Just Reported Earnings, And Analysts Cut Their Target PriceFebruary 22, 2024 | lse.co.ukGenus touts programme to boost investment returns as profit declinesFebruary 22, 2024 | finance.yahoo.comGenus plc Reports Interim Results for the Six Months Ended 31 December 2023February 16, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of Genus plc (LON:GNS)February 15, 2024 | lse.co.ukLondon midday: Stocks dip as investors mull GDP; airlines fly higherFebruary 14, 2024 | wsj.comGenus PLCDecember 31, 2023 | finance.yahoo.comShareholders in Genus (LON:GNS) are in the red if they invested three years agoNovember 25, 2023 | morningstar.comGenus PLC GNSNovember 13, 2023 | finance.yahoo.comInstitutional owners may take dramatic actions as Genus plc's (LON:GNS) recent 5.0% drop adds to one-year lossesNovember 4, 2023 | uk.investing.comLondon midday: Stocks nudge lower; all eyes on payrolls reportSeptember 7, 2023 | msn.comWhy You Should Grow Native Plants in Your GardenSeptember 7, 2023 | finance.yahoo.comGenus plc Preliminary Results for the Year Ended 30 June 2023September 5, 2023 | benzinga.comThinking about buying stock in Scilex Holding, iCoreConnect, Genius Group, Helius Medical Technologies, or TradeUP Acquisition?August 10, 2023 | finance.yahoo.comA Look At The Fair Value Of Genus plc (LON:GNS)July 23, 2023 | finance.yahoo.comGenus' (LON:GNS) earnings trajectory could turn positive as the stock climbs 4.9% this past weekMay 18, 2023 | msn.comPeel Hunt Limited Reiterates Genus (LSE:GNS) Buy RecommendationMay 16, 2023 | uk.investing.comFTSE 100 falls to fresh lows as wall Street makes weak startMay 15, 2023 | finance.yahoo.comShould Weakness in Genus plc's (LON:GNS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?April 27, 2023 | finance.yahoo.comGenus plc (GNS.L)April 22, 2023 | benzinga.comGenius Gr Stock (AMEX:GNS), Short Interest ReportSee More Headlines Receive GNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/28 Dividend2/29/2024Dividend Payable3/28/2024Today5/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:GNS CUSIPN/A CIKN/A Webwww.genusplc.com Phone+44-1256-347100FaxN/AEmployees3,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.51 Trailing P/E Ratio3,627.45 Forward P/E Ratio20.66 P/E Growth2.87Net Income£33.40 million Net Margins4.96% Pretax MarginN/A Return on Equity5.27% Return on Assets3.18% Debt Debt-to-Equity Ratio50.99 Current Ratio2.15 Quick Ratio1.08 Sales & Book Value Annual Sales£673.10 million Price / Sales1.81 Cash FlowGBX 36.59 per share Price / Cash Flow50.56 Book ValueGBX 875 per share Price / Book2.11Miscellaneous Outstanding Shares66,030,000Free FloatN/AMarket Cap£1.22 billion OptionableNot Optionable Beta0.31 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Jorgen Kokke (Age 56)Chief Executive Officer & Director Comp: $586.74kMs. Alison Jane Henriksen ACA (Age 57)CFO & Executive Director Comp: $605kDr. Matt CulbertsonChief Operating OfficerDr. Elena RiceHead of R&D and Chief Scientific OfficerMr. Daniel William David HartleyGroup General Counsel & Company SecretaryMs. Angelle R. RosataGroup Human Resources DirectorMr. Jerry ThompsonGlobal Head of Beef & AquaAndrew ThompsonHead of ABS EMEAMs. Janet DuaneGroup Financial ControllerMore ExecutivesKey CompetitorsOxford Nanopore TechnologiesLON:ONTErgomedLON:ERGOPureTech HealthLON:PRTCSilence TherapeuticsLON:SLNOxford BiomedicaLON:OXBView All CompetitorsInsidersStephen WilsonSold 5,241 sharesTotal: £11.23 M ($2,142.00/share)View All Insider Transactions GNS Stock Analysis - Frequently Asked Questions How have GNS shares performed in 2024? Genus' stock was trading at GBX 2,170 at the start of the year. Since then, GNS shares have decreased by 14.7% and is now trading at GBX 1,850. View the best growth stocks for 2024 here. How often does Genus pay dividends? What is the dividend yield for Genus? Genus announced a dividend on Thursday, February 22nd. Shareholders of record on Thursday, February 29th will be given a dividend of GBX 10.30 per share on Thursday, March 28th. This represents a dividend yield of 0.54%. The ex-dividend date is Thursday, February 29th. The official announcement can be seen at this link. Read our dividend analysis for GNS. Is Genus a good dividend stock? Genus (LON:GNS) pays an annual dividend of GBX 32 per share and currently has a dividend yield of 1.73%. The dividend payout ratio is 6,274.51%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for GNS. What other stocks do shareholders of Genus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE) and Experian (EXPN). How do I buy shares of Genus? Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:GNS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.